Use of a Low Molecular Weight Preparation of Heparin — ORG 10172 (Lomoparan) in the Critically Ill
- 1 November 1991
- journal article
- case report
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 19 (4) , 588-591
- https://doi.org/10.1177/0310057x9101900422
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 20 references indexed in Scilit:
- Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparinEuropean Journal of Clinical Pharmacology, 1990
- Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.Circulation, 1989
- Biochemical and Pharmacologic Inequivalence of Low Molecular Weight HeparinsAnnals of the New York Academy of Sciences, 1989
- Thrombosis prophylaxis with low molecular weight heparin in total hip replacementBritish Journal of Surgery, 1988
- Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationKidney International, 1988
- ORG 10172: a low molecular weight heparinoid anticoagulant with a long half‐life in man.British Journal of Clinical Pharmacology, 1987
- The Heparin StoryActa Medica Scandinavica, 1987
- Low-Molecular-Weight HeparinNew England Journal of Medicine, 1986
- Low Molecular Weight Heparin (KABI2165) as Thromboprophylaxis in Elective Visceral SurgeryThrombosis and Haemostasis, 1986
- A novel anti-thrombotic heparinoid (ORG 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal modelsThrombosis Research, 1982